22nd Century Group (NASDAQ:XXII) Research Coverage Started at StockNews.com
by Michael Walen · The Markets DailyStockNews.com assumed coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a report issued on Monday morning. The firm issued a sell rating on the biotechnology company’s stock.
22nd Century Group Stock Down 4.5 %
Shares of NASDAQ XXII opened at $0.10 on Monday. The company has a 50 day simple moving average of $0.15 and a 200 day simple moving average of $0.53. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.93. 22nd Century Group has a 1 year low of $0.08 and a 1 year high of $5.28. The firm has a market cap of $4.80 million, a PE ratio of 0.00 and a beta of 1.45.
22nd Century Group (NASDAQ:XXII – Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share (EPS) for the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%. The business had revenue of $5.95 million for the quarter.
Institutional Trading of 22nd Century Group
A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP bought a new stake in shares of 22nd Century Group, Inc. (NASDAQ:XXII – Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group as of its most recent SEC filing. Institutional investors and hedge funds own 18.06% of the company’s stock.
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Featured Articles
- Five stocks we like better than 22nd Century Group
- Dividend Payout Ratio Calculator
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Upcoming IPO Stock Lockup Period, Explained
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Do ETFs Pay Dividends? What You Need to Know
- 2 Generic Drug Stocks Ready to Surge in 2025